Recombinant people's IL-2 has become a critical factor in cancer treatment for a range of cancers . This thorough review examines its process of action , including its function in stimulating T-cell expansion and natural killer lymphocyte stimulation . We also consider clinical implementations, difficulties , and prospective directions for refining